S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Aerovate Therapeutics (AVTE) Earnings Date, Estimates & Call Transcripts

$22.05
+0.45 (+2.08%)
(As of 04/19/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

AVTE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVTE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aerovate Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.78) EPS
Next Year EPS Consensus Estimate: ($2.90) EPS

AVTE Earnings Date and Information

Aerovate Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Aerovate Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
11/13/2023Q3 2023($0.70)($0.71)($0.01)($0.71)--
8/14/2023Q2 2023($0.69)($0.76)($0.07)($0.76)--
5/15/2023Q1 2023($0.58)($0.67)($0.09)($0.67)--
3/29/2023Q4 2022($0.58)($0.61)($0.03)($0.61)--
11/14/2022Q3 2022($0.50)($0.56)($0.06)($0.56)--
8/15/2022Q2 2022($0.46)($0.49)($0.03)($0.49)--
5/16/2022Q1 2022($0.26)($0.45)($0.19)($0.45)--
3/30/2022Q4 2021-($0.07)($0.07)($0.07)--
11/14/2021Q3 2021($0.26)($0.26)-($0.26)--
8/15/2021Q2 2021($0.16)($23.80)($23.64)($23.80)--

Aerovate Therapeutics Earnings - Frequently Asked Questions

When is Aerovate Therapeutics's earnings date?

Aerovate Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on AVTE's earnings history.

How much profit does Aerovate Therapeutics generate each year?

Aerovate Therapeutics (NASDAQ:AVTE) has a recorded net income of -$75.52 million. AVTE has generated -$2.88 earnings per share over the last four quarters.

What is Aerovate Therapeutics's EPS forecast for next year?

Aerovate Therapeutics's earnings are expected to decrease from ($2.78) per share to ($2.90) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AVTE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners